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Abstract
In C. elegans, the cell surface protein Sid-1 imports extracellular dsRNA into the cytosol of most non-neuronal cells, enabling
systemic spread of RNA interference (RNAi) throughout the worm. Sid-1 homologs are found in many other animals,
although for most a function for the protein has not yet been established. Sid-1 proteins are composed of an N-terminal
extracellular domain (ECD) followed by 9–12 predicted transmembrane regions. We developed a baculovirus system to
express and purify the ECD of the human Sid-1 protein SidT1. Recombinant SidT1 ECD is glycosylated and spontaneously
assembles into a stable and discrete tetrameric structure. Electron microscopy (EM) and small angle x-ray scattering (SAXS)
studies reveal that the SidT1 ECD tetramer is a compact, puck-shaped globular particle, which we hypothesize may control
access of dsRNA to the transmembrane pore. These characterizations provide inroads towards understanding the
mechanism of this unique RNA transport system from structural prospective.
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Introduction
In the nematode C. elegans, gene-silencing via the RNAi pathway
can spread from cell to cell, throughout most of the body of the
animal. A genetic screen for mutants deficient in this systemic
spread of RNAi identified the gene sid-1 (systemic interference
defective; also termed rsd-8) [1,2]. The encoded protein, Sid-1, is a
transmembrane channel required for importing silencing dsRNA
into living worms [1] When expressed in cultured Drosophila cells
(which lack a sid-1 homolog), the protein promotes a rapid, dose-
dependent dsRNA uptake in an ATP-independent [3] and
dsRNA-gated [4] manner. Strikingly, Sid-1 is capable of efficiently
transporting dsRNA of a large size range (from 21 bp to
.500 bp). The internalized dsRNA is competent for gene
silencing [3,5], and RNA retention is dependent on components
of the RNA-induced silencing complex (RISC) [4]. Sid-1 is
expressed in most non-neuronal cells in the worm, and when
ectopically expressed in neurons, can enhance dsRNA delivery to
these cells as well [6]. C. elegans Sid-1 exogenously expressed in
mammalian cells was also shown to enhance cellular dsRNA
import and silencing [7]. Although the systemic RNAi response in
C. elegans is complex [1,2], involving additional transport factors
[8] as well as Sid-1-independent RNAi export mechanisms [9], C.
elegans Sid-1 is competent and, in some instances, sufficient for
importing silencing dsRNA into the cell.
Sid-1 homologs are present throughout the metazoan kingdom.
The physiological function of the protein in most animals remains
unexplored, but in several cases Sid-1 expression patterns suggest a
role in systemic RNAi. For example, in honeybees exposed to
dsRNA, expression of Sid-1 increased and peaked just before
maximal systemic silencing was observed [10]. Similarly, in the
pacific white shrimp, Litopenaeus vannamei, Sid-1 expression
increased in response to .50 bp dsRNA injection and protected
the organism from viral infection [11]. Interestingly though, knock
down of three distinct Sid-1-like (sil) homologs (individually or in
combination) in the beetle Tribolium castaneum, did not block
systemic RNAi, suggesting the existence of a Sid-1 independent
transport system ([12] and see [13]). Indeed, the fruit fly Drosophila
melanogaster is able to mount a systemic RNAi response when
infected with dsRNA viruses even though flies lack a recognizable
Sid-1 homolog [14], and both the fly and C. elegans can take up
dsRNA via endocytosis mechanisms [2,15,16].
Many vertebrates have two Sid-1 homologs, SidT1 and SidT2,
and evidence exists suggesting that the vertebrate homologs also
mediate dsRNA transport. For example, over-expression of
human SidT1 enabled uptake of dsRNA into cultured human
cells [17]. Likewise, over-expression of SidT2 from the fish Siniperca
chuatsi in fathead minnow epithelial cells increased the uptake of
exogenous dsRNA and also helped protect against viral infection
[18]. Moreover, uptake of lipid-conjugated small interfering RNAs
(siRNAs) into HepG2 cells was blocked by SidT1 knockdown or
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mechanism of uptake is unclear and the physiological role of
SidT1 in mammalian biology is not known. Human SidT1 is
expressed predominantly in lymphocytes and dendritic cells [19].
Human SidT2 is more ubiquitously expressed [19], and
interestingly, mouse SidT2 was shown to localize predominantly
in lysosomes [20]. Therefore, compared to C. elegans Sid-1, the
functions of the Sid-1 homologs in vertebrates may be more
diverse and are certainly less well understood.
Sequence analysis and biochemical experiments suggest that
Sid-1 proteins are composed of a large N-terminal extracellular
domain and 9–12 transmembrane segments, with an intervening
cytosolic loop between segments 1 and 2 [3]. Dominant negative
effects of Sid-1 mutants in over-expression experiments suggest the
protein functions as an oligomer [5]. Beyond these basic
characterizations and predictions very little is known about the
structure of the protein and tools for probing the protein’s
structure are still being developed. Here we show that the
extracellular domain of the human homolog SidT1 (SidT1 ECD)
can be expressed and purified using a baculovirus system. The
purified recombinant protein is glycosylated and spontaneously
forms a defined oligomeric structure, most consistent with a
tetramer. EM and SAXS measurements suggest that the SidT1
ECD oligomerizes into a compact, puck-shaped globular particle.
This study is the first structural characterization of the Sid-1 ECD
and paves way for understanding the mechanism and function of
the Sid-1 family of proteins.
Results
Recombinant SidT1 ECD folds into a stable soluble
structure
All Sid-1 homologs have a ,300 amino acid N-terminal ECD,
which is predicted to form a globular, soluble domain with defined
secondary structure (Figure S1, discussed below). To test this
prediction directly we attempted to produce isolated forms of the
Sid-1 ECD. Initial efforts focused on expressing ECDs of Sid-1
homologs as C-terminal fusions to the maltose-binding protein
(MBP) in E. coli. ECDs of Sid-1 homologs from humans
(AAI17223 and AAI14523), C. elegans (NP_504372), Branchiostoma
floridae (XP_002597180), and Strongylocentrotus purpuratus
(XP_789210) were tested. Although we could produce milligram
quantities of each protein, folding defects were always apparent –
the proteins co-purified with the chaperone GroEL and eluted in
the void volume of size exclusion columns, suggesting that they
had formed large, soluble aggregates. Moreover, removal of the
MBP tag led to rapid degradation of the purified Sid-1 ECD
polypeptides (data not shown). These observations led us to
postulate that either Sid-1 ECDs do not form globular structures
outside of the full-length protein, or that endogenous Sid-1 ECDs
might have posttranslational modifications, absent in bacterial
expression systems, that are required for proper protein folding.
To explore these possibilities we established a baculovirus system
for expression of secreted Sid-1 ECD proteins in insect cells.
We constructed a modified version of pFastBac HT A for the
expression of secreted proteins under control of the Autographa
californica multicapsid nuclear polyhedrosis virus GP64 promoter.
The construct included an N-terminal His6-tag to be used for
protein detection and purification. Our major efforts focused on
characterization of the ECD of human SidT1 (isoform 1 of Sid-1
in humans). Baculoviruses encoding the SidT1 ECD were
produced in Sf9 cells, and then used to infect either Sf9 or Tni
cells. After 1–3 days of infection, the medium was cleared of cells
and large debris by centrifugation and filtration and assessed for
the presence of soluble SidT1 ECD.
To assay for Sid-1 ECD in the culture meduim we performed
small-scale fractionation of the medium by Ni-affinity chromatog-
raphy. We noticed, however, that the insect cell medium we used
contains metal-chelating compounds that cause leaching of Ni
2+
and Co
2+ from metal-affinity resins and interfere with the ability of
the resins to bind His6-tagged proteins. The interfering activity
could be removed by dialyzing the medium against Ni-affinity
wash buffer. The post-infection medium contained a soluble
protein that could be purified by Ni-affinity chromatography and,
judging from SDS PAGE, was the approximate molecular weight
of the SidT1 ECD. Anti-His6 Western blots also revealed the
presence of a soluble protein with the approximate size of the
SidT1 ECD in the medium 24–48 hours post infection, and
tandem liquid chromatography mass spectrometry (MS) identified
the isolated protein as SidT1 (data not shown). Therefore,
recombinant SidT1 ECD can fold into a soluble form that is
stable enough to accumulate to significant levels (.1 mg/L) in cell
culture medium.
We next devised a protocol for large-scale preparation of SidT1
ECD for biochemical and biophysical studies. An expression time
course revealed that 48 hours was optimal for expression of SidT1
in Sf9 cells and 24 hours was optimal in Tni cells (data not shown).
For large-scale preparations, dialysis of the clarified medium was
an impractical method for removing the metal-chelating activity.
As an alternative, we passed the medium through a fast-flow cation
exchange column, which served to concentrate the protein and
remove most of the metal-chelating activity. Eluted protein
samples were then subjected to Ni-affinity purification, His-tag
removal (using TEV protease), and size exclusion chromatogra-
phy. This procedure generated 0.5–1 mg of ,99% pure SidT1
ECD protein per liter of cultured insect cells. Due to favorable
yield and expression kinetics, we usually produced SidT1 ECD
samples in Tni cells. However, Sf9 cells have the benefit of
producing PNGaseF-sensitive glycoproteins [21], which were
useful in deglycosylation studies (see below).
Post-translational modification of SidT1 ECD in insect
cells
Purified SidT1 ECD migrated as two species on SDS-PAGE,
both of which were higher than 34 kDa, the predicted molecular
weight of the protein (Figure 1A). Nonetheless, both species were
separately identified as SidT1 using tandem liquid chromatogra-
phy mass spectrometry (data not shown). Likewise, MALDI-TOF
MS identified at least two species of 36.3 and 37.4 kDa (Figure 1B).
Native SidT1 is presumably folded in the endoplasmic reticulum,
where it would be susceptible to post-translational modifications,
such as N-terminal glycosylation. The protein also contains
potential phosphorylation sites [22]. To assay for the presences
of these two types of modification in our recombinant samples we
treated purified SidT1 with either lambda phosphatase or N-
Glycosidase F (PNGaseF) enzymes. Treatment with phosphatase
had no visible effect on the electrophoretic mobility of the protein
on SDS PAGE. In contrast, glycosidase treatment caused a
substantial increase in electrophoretic mobility (Figure 1C),
suggesting the SidT1 ECD produced in insect cells is N-
glycosylated. Glycoslyation is likely to be essential for proper
protein folding as we noted dramatic reductions in yield when
expressing glycosylation site mutants or adding the glycosylation
inhibitors kifunensine, swainsonine or tunicamycin to the growth
medium during viral infection. We were also unable to detect any
SidT1 ECD when expression was directed to the cytoplasm of
insect cells.
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tetrameric structure
Functional characterization of a dominant negative mutant of C.
elegans Sid-1 led to the proposal that the full-length protein functions
as an oligomer [5]. Interestingly, we also observed evidence for
oligomerization of the SidT1 ECD. During the final stages of
purification, theproteinoftenelutedasthreedistinctpeaksfrom the
sizeexclusioncolumn(Figure2A).Comparingtoelutionvolumesof
molecular weight standards, we estimate that the three peaks
correspond to particles with molecular masses of 41 kDa, 89 kDa
and177 kDa.Theratioofthesemassesisthus0.9:2:4,whichismost
consistent with monomeric, dimeric and tetrameric forms of the
SidT1 ECD [although because the estimated mass of the highest
molecular weight species is 1.26 greater than 148 kDa, the
calculated mass of a tetramer based on MALDI-TOF of the
denatured form of the protein (,37 kDa) we cannot rule out the
possibility of a pentamer with certainty]. Re-injection of the
fractions containing the putative tetramer did not result in a
redistribution of species to the dimeric and monomeric forms,
revealing that three oligomeric species are not in rapid equilibrium
with each other (data not shown). Furthermore, when the
concentrated protein was incubated on ice for several hours before
injecting into the column, only the largest species was observed,
suggesting that the tetramer is the final, most stable form of the
protein (Figure 2B). We also noted that treatment of SidT1 ECD
with PNGaseF did not affect the oligomeric state of the protein
(Figure S2). Therefore, we hypothesize recombinant SidT1 ECD
assembles into a stable and discrete tetrameric structure.
Figure 1. Recombinant SidT1 ECD is a glycoprotein. A, Heterogeneity in purified SidT1 ECD samples. Double arrows indicate the presence of
two bands on SDS-PAGE. B, MALDI-TOF mass spectrum reveals a mixture of two major species of 36.3 and 37.4 kDa. C, N-Glycosidase F treatment of
the protein resulted in increased electrophoretic mobility, suggesting N-linked glycosylation. Lambda phosphatase treatment had no noticeable
effect.
doi:10.1371/journal.pone.0033607.g001
Figure 2. Mature SidT1 ECD forms an oligomer. Size exclusion
elution profiles from a Superdex 200 column are displayed. A,
Concentrated protein applied directly to the column, with no pre-
incubation period, elutes as three species with sizes consistent with
monomeric, dimeric and tetrameric forms of the protein. B, Following
an incubation period of two hours, the protein elutes as a
homogeneous tetrameric species.
doi:10.1371/journal.pone.0033607.g002
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To test our hypothesis that SidT1 ECD forms stable tetramers
in solution, we further characterized these particles using small
angle X-ray scattering (SAXS). SAXS determines the basic
parameters describing the size and shape of the particle
(Figure 3A, B, C) [23,24], revealing that SidT1 ECD has: a
radius-of-gyration of approximately 35 A ˚, a maximal dimension of
,110 A ˚ and a molecular weight in the range of 160–165 kDa,
using the SAXS MoW server [25] (see Table S1). The SidT1 ECD
also appears to be a compact and relatively rigid molecule – unlike
flexible polymers, which display a 1/q
2 scattering dependency, the
SidT1 ECD data exhibits a 1/q
4 dependency (Porod expo-
nent=3.9), indicative of a well-folded, compact particle [26]. The
parabolic shape of the Kratky plot is also characteristic of
foldedness and minimal flexibility (Figure 3C).
Imposing P4 symmetry, we used the SAXS data to calculate an
ab initio 3D model of the SidT1 ECD. The resulting model is a
disc-shaped particle (Figure. 4A). Importantly, the SAXS structure
is consistent with electron micrographs of negatively stained SidT1
ECD, which contained particles of similar shape and dimension
(Figure 4B). Calculating models with P3 or P5 symmetry also
resulted in disc shaped particles; however these models did not fit
the data as well as P4 (Figure S5). The P3 models were less
reproducible, with a mean normalized spatial discrepancy (NSD)
value significantly greater than that of the P4 models (1.40 versus
1.05, respectively). The data did also not fit the P5 model as well as
the P4 model (the average X
2 was 2.6 and 1.8 for P5 and P4,
respectively). Furthermore, based on the scattering data, the
estimated protein density for a pentamer would be .1.4 g/cm
2,
which is higher than commonly observed [26]. Therefore, these
analyses further suggest that the SidT1 ECD is a tetrameric
particle in solution.
We also modeled our data SAXS data using P222 symmetry.
The resulting averaged model is an oblate spheroid shape that is
similar to the P4 model, though slightly more elongated in one
direction perpendicular to the P4 symmetry axis (Figure S5). P222
and P4 fit the data equivalently well (X
2 is 1.8 and 1.7 for P222
and P4, respectively) and it is not possible for us to distinguish
between these two symmetries with the present analysis. However,
the overall results reveal that SidT1 ECD forms a well-folded,
compact, disc-like tetrameric glycoprotein ,110 A ˚ in maximal
diameter. The non-spherical shape of the particle explains the
erroneously high native molecular weight estimated by size-
exclusion chromatography (Figure 2A).
Discussion
This work describes the first preparation of any domain of a Sid-
1 protein. We found SidT1 ECD folds efficiently in a eukaryotic
secretory pathway and is secreted in a soluble form. We were
unable to detect SidT1 ECD when expression was targeted to the
cytoplasm of insect cells (by removal of the signal sequence) and
noted diminished expression levels when glycosylation of the
protein was affected, either by expressing N-linked glycan site
mutants or using glycosylation inhibitors (data not shown). We
therefore suspect that glycosylation is important for folding and/or
stability of the protein. We also note, however, that the full extent
of glycosylation present is not required for stability of the mature
SidT1 ECD tetramer as partial degylcosylation did not substan-
tially affect the native molecular weight of the oligomer (Figure
S2). Recombinant forms of ECDs from human SidT2 (Figure S3)
and C. elegans Sid-1 (Figure S3, S4) also appear to be glycosylated.
Endogenous mouse SidT2 from liver tissue extracts was recently
found to contain significant glycosylation [20] – thus, this post-
translational modification appears to be a common feature of Sid-
1 proteins.
The isolated SidT1 ECD is remarkably stable: The crude,
secreted protein accumulated in cell culture medium incubated at
27uC, and, the final, purified sample remained completely intact
after a 1-week incubation at room temperature (data not shown).
During many preparations we observed what appeared to be
monomeric, dimeric and tetrameric forms of the protein.
Curiously, incubating the protein at high concentrations facilitated
the assembly of stable ECD tetramers. We do not yet know if the
tetrameric form of the protein is biologically relevant or why
assembly of the tetramer is slow. However, we did find that once
Figure 3. SidT1 SAXS analysis. A, Solution SAXS profile for
glycosylated SidT1 ECD. Inset displays Guiner region (data ,q=0.028,
beyond light gray line, were omitted in subsequent modeling). B, P(r)
plot of SidT1 ECD reveals a unimodal curve, consistent with a globular
protein species. The maximum particle diameter, Dmax, is 110 A ˚. C,
Kratky plot of SAXS data shows very little flexibility/looseness, indicated
by the convergence of the curve. The Porod exponent is 3.9.
doi:10.1371/journal.pone.0033607.g003
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that this is a discrete and defined oligomerization end point.
Moreover, upon dilution, the assembled tetramer did not
dissociate back into monomers or dimers, suggesting that this
may be the mature form of the protein. We hypothesize that the
slow rate of assembly may be a consequence of the examining the
protein in free solution and that oligomerization of the full-length
protein, on the surface of a cell membrane, could be considerably
faster. It is also possible that oligomerization may be controlled as
a way of regulating transport activity. Consistent with this idea, the
full length C. elegans Sid-1 functions as an oligomer [5]. Indeed,
many transport channels function as symmetric homooligomers
(e.g. glutamate transporters [27]; cyclic nucleotide-gated ion
channels; [28] aquaporins [29]; potassium channels [30]).
Considering the stability of the ECD tetramer it is also conceivable
ECD oligomerization could drive formation of the oligomeric Sid-
1 pore.
We found that the SidT1 ECD forms a tetrameric, puck-shaped
molecule (Figure 4A). Although we could not distinguish between
P4 and P222 symmetries using SAXS data, we are inclined to
favor the P4 model, as cyclic symmetry is a common feature in
membrane proteins with sidedness and/or directionality with
respect to the cellular membrane [31]. Because the ECD is the
major extracellular portion of Sid-1 it is likely to play a role in
substrate recognition, or pore gating, or both. Consistent with this
notion, several alleles encoding point mutations that impair import
have been identified in the ECD of C. elegans Sid-1 [1,32]. We
speculate that the puck-shaped Sid-1 ECD may sit in the aqueous
environment atop the transmembrane domains, possibly control-
ling access to the channel. Interestingly, between the Sid-1
homologs found throughout metazoa, the ECD is the most
divergent region of the protein, suggesting that different animal
species may have evolved the ECD to confer different functional
properties. However, alignment of ECD sequences from several
representative Sid-1 homologs revealed a common pattern of
predicted secondary structure elements. The secondary structure is
predicted to be predominately ß-strands with two large disordered
regions that are variable in sequence between Sid-1 homologs
(Figure S1). Indeed, limited proteolysis of the C. elegans Sid-1 ECD
revealed a protease sensitive site likely in variable region 1 (Figure
S3B and S4C). The combined observations suggest that the ß-rich
ECD fold is conserved among Sid-1 homologs, and thus the
biophysical features of the SidT1 ECD reported here may be
common to Sid-1 homologs throughout metazoa.
Materials and Methods
Plasmid Construction
The expression plasmid, pFB-GP64, was constructed by PCR-
amplifying the GP64 promoter and signal sequence from pBAC6
(Novagen), and subcloning into pFastBac HTA (Invitrogen), (see
Table S2 for primer sequences and details). The coding region of
SidT1 ECD was amplified from a cDNA clone (IMAGE
40125773, Open Biosystems) of full-length SidT1 and cloned as
an SfoI-XhoI fragment into the pFB-GP64 plasmid. The resulting
plasmid (SidT1-ECD/pFB-GP64) was used in the Bac-to-Bac
system (Invitrogen) to generate baculovirus that induce secretion of
the SidT1 ECD from insect cells. The encoded protein bears an
N-terminal His6-tag and tobacco etch virus (TEV) protease site.
The final purified protein, following signal peptidase and TEV
cleavages, was composed of residues 19–304 (Entrez Protein
accession AAI17223), with an N-terminal glycine appendage from
the protease site. Baculovirus encoding human SidT2 and C.
elegans Sid-1 ECDs were produced in the same way. The SidT2
construct encoded residues 19–292 (taken from AAI14523) and
the C. elegans construct contained residues 17–313 (from
NP_504372). Both recombinant proteins contained an additional
N-terminal glycine-alanine dipeptide after cleavage by the TEV
protease.
Protein Expression
Spodoptera frugiperda 9 (Sf9) or Trichoplusia ni (Tni) cells were
obtained from Expression Systems (Woodland, CA) and cultured
in ESF 921 medium (Expression Systems) containing 0.56
Antibiotic/Antimycotic solution (Gibco). To produce DNA for
generating baculovirus, SidT1-ECD/pFB-GP64 was transformed
into DH10-Bac E. coli (Invitrogen), and bacmid DNA was purified
from 2 mL overnight LB cultures using alkaline lysis (Qiagen
Figure 4. 3D model of the SidT1 ECD. A, Averaged 3D reconstruction of SAXS data using Gasbor software and P4 symmetry reveals a puck-like
shape. B, Transmission electron micrograph showing negatively-stained SidT1 ECD particles.
doi:10.1371/journal.pone.0033607.g004
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Bacmid DNA was transfected into Sf9 cells using Fugene 6
(Roche). Baculovirus was purified from infected cells and debris 7
days post-transfection by centrifugation and filtration. Three
successive viral amplifications were performed, such that viral
stocks were used to infect increasing cell volumes for shorter
periods of time until the stocks reached optimal titer. Optimal titer
was determined empirically by observing viral-induced growth
arrest and swelling of infected expression host cells. The kinetics of
SidT1 ECD protein expression were monitored by anti-His tag
Western blot analysis or small scale Ni affinity purification
(described below).
Protein Purification
For small-scale test expressions, 10–20 mL of cell culture
medium containing SidT1 ECD was clarified by centrifugation
then dialyzed against nickel-resin wash buffer (20 mM sodium
phosphate, 0.5 M NaCl, 0.5 mM TCEP, 20 mM imidazole,
pH 8). Dialyzed medium was incubated with two hundred
microliters of His Select resin (Sigma) for 10 minutes. The resin
was pelleted by brief centrifugation and bound protein was eluted
into 50 mL of wash buffer containing 250 mM total imidazole.
For large-scale preparations, SidT1 ECD was purified directly
from the cell growth medium, following a 20-minute centrifuga-
tion step at 60006g to remove cells and debris. Clarified medium
was loaded onto a 20 ml column of SP Fast Flow (GE Healthcare
Life Sciences), pre-equilibrated in 50 mM sodium phosphate,
pH 6.5, 25 mM NaCl and 0.5 mM TCEP, and was washed with
the same buffer until UV absorbance reached a constant baseline.
SidT1 was eluted from the column in a step elution with buffer
containing 50 mM sodium phosphate, pH 8, 0.5 M NaCl and
0.5 mM TCEP. SidT1 ECD-containing fractions (,5 column
volumes) were pooled, adjusted to 20 mM imidazole using a 3 M
stock (pH 8), and directly applied to up to 5 mL of His-Select
Nickel resin (Sigma) equilibrated in nickel-resin wash buffer. After
a 60-minute incubation with the resin, SidT1 ECD was washed
extensively with the same buffer in batch centrifugation format.
The protein was eluted with 3 column volumes of nickel-column
elution buffer (20 mM sodium phosphate, 0.5 M NaCl, 0.5 mM
TCEP, 250 mM imidazole, pH 8). The TEV protease was added
to the eluate and the mixture was dialyzed against nickel-column
wash buffer overnight. The TEV-treated, dialyzed sample was
passed through a 1 or 5 mL His-trap column (GE Healthcare Life
Sciences) and then concentrated using an Amicon Ultra
centrifugal filter (Amicon). Concentrated samples were allowed
to equilibrate up to several hours on ice and then applied a
Superdex 200 10/300 GL column (GE Healthcare Life Sciences)
equilibrated in 20 mM HEPES, pH 8, 100 mM NaCl, 0.5 mM
TCEP. The eluted protein was concentrated as above and stored
at 280uC in 100 mL aliquots at 10 mg/mL, or used immediately.
All purification steps were performed at 4uC.
Protein analysis
Protein purity was assessed by SDS PAGE using Coomassie
Staining (Denville Blue) or by Western Blotting using an alkaline-
phosphatase conjugated anti-His6-tag antibody (Sigma) and
colorimetric detection in a solution containing 100 mM Tris,
pH 9.6, 100 mg/mL nitro blue tetrazolium, 4 mM MgCl2 and
50 mg/mL 5-bromo-4-chloro-3-indolyl-phosphate. MALDI-TOF
mass spectrometry analyses were performed at the Scripps
Research Institute Center for Metabolomics and Mass Spectrom-
etry. Deglycosylation was done on an analytical scale using
PNGaseF from New England Biolabs, or on a preparative scale
using purified recombinant PNGaseF (a gift from Dr. Raymond
Stevens’ lab). The optimal enzyme concentration was determined
empirically and was generally performed in nickel-column wash
buffer. Native molecular weights were estimated on a Superdex
200 10/30 size exclusion column that was calibrated using an
HMW Calibration Kit (GE Healthcare Life Sciences).
Limited proteolysis of C. elegans Sid-1 ECD was performed as
follows: Two microliters of a dilute trypsin solution (10 mg/mL
trypsin in 25 mM Tris, pH 7.5, 150 mM NaCl) was added to to
2 mg of purified C. elegans Sid-1 ECD in a total volume of 15 mL.
The reaction proceeded for about 3 minutes at room temperature
and was stopped by the addition of SDS-PAGE loading buffer.
The sample was flash frozen in liquid nitrogen and stored frozen
until analysis by SDS PAGE.
Electron Microscopy
A purified sample of SidT1 extracellular domain was adhered
onto a carbon-coated C-flat grid and negatively-stained using 2%
uranyl acetate. Micrographs were taken on a FEI Morgagni
microscope at 80 kV on a 2 k62 k CCD camera. Particles
appeared well dispersed with an approximate size of 10 nm.
Small Angle X-ray scattering
Small angle X-ray scattering (SAXS) data were collected on
20 mL samples of purified SidT1 ECD (not treated with glycosidase)
at 2.5 mg/mL in phosphate buffered saline containing 0.5 mM
TCEP, at 16uC, using a MAR CCD 165 detector on the SIBYLS
beamline 12.3.1 at the Advanced Light Source. The x-ray
wavelength (l) was 1 A ˚, and the sample-to-detector distance was
1.5 m, corresponding to a scattering vector q (q=4p sin h/l, where
2h is the scattering angle) range of 0.01 to 0.32 A ˚ 21. Exposures of
0.5, 1 and 6 seconds were taken for both the sample and a buffer
blank. Scattering of the buffer blank was subtracted from that of the
protein, and exposure data sets were merged with PRIMUS [33]
using lowexposure data for the low-q region and high exposure data
for the high-q region. PRIMUS was also used to calculate the radius
of gyration (RG) using the Guinier approximation for the low-
resolution data (qRG,1.3). The P(r) function, Rg (real space
approximation) and maximum distance Dmax were calculated with
GNOM [34]. Usingthedata range of0.028 to 0.29 A ˚ 21,GASBOR
[35] was used to generate 10 independent 3D models in several
different symmetry groups. The independent models were aligned
and averaged using DAMAVER [36]. For P3 modeling, 1 of the 10
models was rejected by DAMAVER and not used in subsequent
averaging. Chi squared values reported are the mean of the
independent runs. Normalized spatial discrepancy (NSD) values are
reported as the mean value with variability for each symmetry
group (Table S1). SAXS data were deposited in the Bioisis database
(code SIDT1P, www.bioisis.net).
Sequence alignment and secondary structure prediction
Sid-1 homolog ECD sequences were aligned using the
ClustalW2 server (http://www.ebi.ac.uk/Tools/msa/clustalw2/)
[37], with minor manual adjustments. Secondary structure was
predicted using the Phyre server (http://www.sbg.bio.ic.ac.uk/
˜phyre/) [38]. Secondary structural elements with confidence
scores of 5 and higher (on a scale of 1–10) were mapped on the
sequence alignment.
Supporting Information
Figure S1 Secondary structure prediction suggest ECDs
of Sid-1 homologs share a conserved fold. Aligned Sid-1
ECD sequences display conservation of predicted secondary
structural elements. Sid-1 ECDs are predicted to be ß -strand
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beginning of ß11, and most homologs (aside from Caenorhabditis
orthologs) share a second pair of conserved cysteines in the
variable 1 and ß11/ß12 linker regions. Predicted sites of N-linked
glycosylation are not as well conserved, although some N-enriched
regions are evident. Sequences examined include Homo sapiens
SidT1 (Genbank AAI17223.1); Xenopus (Silurana) tropicalis SidT1
(NCBI XP_002941891.1); Homo sapiens SidT2 (Genbank
AAI14523.1); Siniperca chuatsi SidT2 (Genbank ADG29120.1);
Tribolium castaneum Sid-1 related (Genbank EFA10693.1); Apis
mellifera SidT1 (NCBI XP_395167.4); Caenorhabditis elegans Sid-
1(NCBI NP_504372.2); Caenorhabditis remanei Sid-1 (NCBI
XP_003113953.1); Strongylocentrotus purpuratus SidT2 (NCBI
XP_001176487.1). Interestingly, the sea urchin Sid-1 homolog
appears circularly permuted, with the predicted ECD appearing in
the middle of the primary sequence.
(TIF)
Figure S2 Glycosidase-treated SidT1 ECD maintains its
oligomeric state. PNGaseF-treatment of the SidT1 ECD
tetramer increases gel filtration elution volume only very slightly,
indicating that the quaternary structure remains intact. Left axis
corresponds to absorbance of untreated protein, and right axis
corresponds to the PNGaseF-treated sample.
(TIF)
Figure S3 Expression and Purification of Sid-1 homolog
ECDs. A, Western blot against the His6 purification tag reveals
expression of recombinant human or C. elegans Sid-1 ECDs in
growth medium of infected Sf9 cells. Recombinant ECDs of
human SidT1 (T1), SidT2 (T2), and C. elegans Sid-1 (C) are
labeled. B, SDS PAGE of Sid-1 ECD proteins after cation
exchange chromatography. C, SDS PAGE of a purified SidT2
ECD sample after cation exchange, nickel affinity and gel filtration
purification steps.
(TIF)
Figure S4 Characterization of recombinant C. elegans
Sid-1 ECD. A, PNGaseF treatment of the C. elegans Sid-1 ECD
results in increased mobility of the protein sample in SDS-PAGE.
B, Limited proteolysis of the protein results in the release of two
lower molecular weight species. C, Schematic of the ECD, with
respect to the full-length protein, and depiction of the likely trypsin
sensitive sites (red scissors). Seven predicted N-linked glycan sites
(purple stars) are shown in the cartoon. Molecular weights are
theoretical estimates based on the likely trypsin cleavage sites, and
do not account for glycosylation.
(TIF)
Figure S5 Ab Initio 3D Models of SidT1 ECD in
Different Spacegroups. P3, P4, P222 and P5 symmetries were
imposed in modeling runs using GASBOR. Models shown are the
averages of 10 independent runs (except for the P3 models, in
which 9 are averaged). Chi-squared and normalized spatial
discrepancy (NSD) values are indicated.
(TIF)
Table S1 Data Summary. Calculated and derived values are
listed for biophysical measurements, basic SAXS parameters and
3D modeling runs.
(TIF)
Table S2 Primers for constructing the pFB-GP64 plas-
mid. pFBHTA-NdeI-QC-For and -Rev are site directed
mutagenesis primers used to introduce a unique NheI site in
pFastBac HT A. PCR amplification of the GP64 promoter from
pBac6 used NdeI-GP64 and GP64-SfoI-Rev for directional
cloning into the NheI-modified pFastBac HT A, using NheI and
SfoI restriction sites. This strategy removes the His6 tag from the
original plasmid, allowing constructs of interest to be cloned as
fusion proteins to the GP64 secretion sequence, using any of the
original multiple cloning sites downstream of the SfoI site in
pFastBac HT A.
(TIF)
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